Eupraxia Pharmaceuticals enters sales agreement establishing ATM program
EPRX•Eupraxia Pharmaceuticals entered a sales agreement that allows it to offer and sell up to US$125 million of common shares through an ATM program. The company has no current plan to use the program in the near term, a SEC filing said.
1. ATM program
Eupraxia Pharmaceuticals entered a sales agreement with Jefferies LLC and Jefferies Securities, Inc. that allows it to offer and sell up to US$125 million of its common shares through an at-the-market program. The company has no current plan to use the program in the near term, a SEC filing said.
